Skip Header

 

4 results for uniprot:Q8TE24Drop in citationmapping

Customize display Download...

Page 1 of 1

Evidence of native starch degradation with human small intestinal maltase-glucoamylase (recombinant).

Ao Z., Quezada-Calvillo R., Sim L., Nichols B.L., Rose D.R., Sterchi E.E., Hamaker B.R.

FEBS Lett. 581:2381-2388(2007) GeneRIF 8972 · Mapped (3)
Raw starch granule degradation with recombinanat human MGAM indicates that pancreatic alpha-amylase hydrolysis is not a requirement for native starch digestion in the human small intestine. GeneRIF 8972

Human intestinal maltase-glucoamylase: crystal structure of the N-terminal catalytic subunit and basis of inhibition and substrate specificity.

Sim L., Quezada-Calvillo R., Sterchi E.E., Nichols B.L., Rose D.R.

J. Mol. Biol. 375:782-792(2008) GeneRIF 8972 · UniProtKB (1) · Mapped (2)
Intestinal maltase-glycoamylase: crystal structure of the N-terminal catalytic subunit and basis of inhibition and substrate specificity. GeneRIF 8972

Clinical, endocrine, and metabolic effects of acarbose, a alpha-glucosidase inhibitor, in overweight and nonoverweight patients with polycystic ovarian syndrome.

Tugrul S., Kutlu T., Pekin O., Baglam E., Kiyak H., Oral O.

Fertil. Steril. 90:1144-1148(2008) GeneRIF 8972 · Mapped (3)
Acarbose has been found to improve insulin levels and thus glucose/insulin ratios more effectively in overweight patients compared with nonoverweight patients with PCOS. GeneRIF 8972

A novel mutation of the GAA gene in a Finnish late-onset Pompe disease patient: clinical phenotype and follow-up with enzyme replacement therapy.

Korpela M.P., Paetau A., Lofberg M.I., Timonen M.H., Lamminen A.E., Kiuru-Enari S.M.

Muscle Nerve 40:143-148(2009) GeneRIF 8972 · Mapped (3)
This study reported the first diagnosed Finnish patient with a phenotype compatible with the late-onset form of Pompe disease. Molecular genetic analysis of the GAA gene revealed a novel missense mutation (Y575X) combined with (P545L) mutation. GeneRIF 8972

Page 1 of 1